Paclitaxel-containing High-dose Chemotherapy in High-risk Breast Cancer Patients

Author： Greinix Hildegard T.   Linkesch Werner   Seifert Manfred   Kubista Ernst   Czerwenka Klaus   Elahi Fariborz   Zielinski Christoph   Hoecker Paul   Steger Günther   Schulenburg Axel   Neumeister Geralt   Rabitsch Werner   Jakesz Raimund   Kalhs Peter  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.39, Iss.1, 2000-04, pp. : 47-52

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adjuvant Dose-Dense Sequential Chemotherapy with Epirubicin, CMF and Weekly Paclitaxel in Patients with Resected High-Risk Breast Cancer: A Hellenic Cooperative Oncology Group (HeCOG) Study

By Papadimitriou Christos   Papakostas Pavlos   Timotheadou Eleni   Aravantinos Gerasimos   Bamias Aristotelis   Fountzilas George  

Cancer Investigation, Vol. 26, Iss. 5, 2008-06 ,pp. : 491-498

Informa Healthcare

Access to resources Recommend Favorite

Effects of dose-intensive chemotherapy and radiotherapy on serum n-terminal proatrial natriuretic peptide in high-risk breast cancer patients

By Hall K.S.  

Breast Cancer Research and Treatment, Vol. 67, Iss. 3, 2001-06 ,pp. : 235-244

Springer Publishing Company

Access to resources Recommend Favorite

A Phase I Toxicity and Feasibility Trial of Sequential Dose-Dense Induction Chemotherapy with Doxorubicin, Paclitaxel, and 5-Fluorouracil Followed by High Dose Consolidation for High-Risk Primary Breast Cancer

By Emens L.A.   Kennedy M.J.   Fetting J.H.   Davidson N.E.   Garrett E.   Armstrong D.K.  

Breast Cancer Research and Treatment, Vol. 76, Iss. 2, 2002-11 ,pp. : 145-156

Springer Publishing Company

Access to resources Recommend Favorite

The Toxicity of Radiotherapy Following High-dose Chemotherapy With Peripheral Blood Stem Cell Support in High-risk Breast Cancer: A Preliminary Analysis

By van der Wall E.   Schaake-Koning C.C.E.   van Zandwijk N.   Baars J.W.   Schornagel J.H.   Richel D.J.   Rutgers E.J.T.   Borger J.H.   Beijnen J.H.   Rodenhuis S.  

European Journal of Cancer, Vol. 32, Iss. 9, 1996-08 ,pp. : 1490-1497

Elsevier

Access to resources Recommend Favorite

Acute and Late Toxicity Following Adjuvant High-Dose Chemotherapy for High-Risk Primary Operable Breast Cancer A Quality Assessment Study

By Svane Inge M.   Homburg Keld M.   Kamby Claus   Nielsen Dorte L.   Roer Ole   Sliffsgaard Dorte   Johnsen Hans E.   Hansen Steen W.  

Acta Oncologica, Vol. 41, Iss. 7-8, 2002-11 ,pp. : 675-683

Informa Healthcare

Access to resources Recommend Favorite